文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Eliciting the child's voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative.

作者信息

Reeve Bryce B, McFatrich Molly, Pinheiro Laura C, Weaver Meaghann S, Sung Lillian, Withycombe Janice S, Baker Justin N, Mack Jennifer W, Waldron Mia K, Gibson Deborah, Tomlinson Deborah, Freyer David R, Mowbray Catriona, Jacobs Shana, Palma Diana, Martens Christa E, Gold Stuart H, Jackson Kathryn D, Hinds Pamela S

机构信息

Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.

Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina.

出版信息

Pediatr Blood Cancer. 2017 Mar;64(3). doi: 10.1002/pbc.26261. Epub 2016 Sep 21.


DOI:10.1002/pbc.26261
PMID:27650708
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5301979/
Abstract

BACKGROUND: Adverse event (AE) reporting in oncology trials is required, but current practice does not directly integrate the child's voice. The Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) is being developed to assess symptomatic AEs via child/adolescent self-report or proxy-report. This qualitative study evaluates the child's/adolescent's understanding and ability to provide valid responses to the PRO-CTCAE to inform questionnaire refinements and confirm content validity. PROCEDURE: From seven pediatric research hospitals, children/adolescents ages 7-15 years who were diagnosed with cancer and receiving treatment were eligible, along with their parent-proxies. The Pediatric PRO-CTCAE includes 130 questions that assess 62 symptomatic AEs capturing symptom frequency, severity, interference, or presence. Cognitive interviews with retrospective probing were completed with children in the age groups of 7-8, 9-12, and 13-15 years. The children/adolescents and proxies were interviewed independently. RESULTS: Two rounds of interviews involved 81 children and adolescents and 74 parent-proxies. Fifteen of the 62 AE terms were revised after Round 1, including refinements to the questions assessing symptom severity. Most participants rated the PRO-CTCAE AE items as "very easy" or "somewhat easy" and were able to read, understand, and provide valid responses to questions. A few AE items assessing rare events were challenging to understand. CONCLUSIONS: The Pediatric and Proxy PRO-CTCAE performed well among children and adolescents and their proxies, supporting its content validity. Data from PRO-CTCAE may improve symptomatic AE reporting in clinical trials and enhance the quality of care that children receive.

摘要

相似文献

[1]
Eliciting the child's voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative.

Pediatr Blood Cancer. 2017-3

[2]
Cognitive Interview-Based Validation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in Adolescents with Cancer.

J Pain Symptom Manage. 2017-4

[3]
Mapping child and adolescent self-reported symptom data to clinician-reported adverse event grading to improve pediatric oncology care and research.

Cancer. 2019-9-25

[4]
Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

Qual Life Res. 2013-7-20

[5]
Validity and Reliability of the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events.

J Natl Cancer Inst. 2020-11-1

[6]
Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

J Am Med Inform Assoc. 2019-4-1

[7]
Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

JAMA Oncol. 2015-11

[8]
Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).

J Natl Cancer Inst. 2014-9-29

[9]
Reliability and Validity of the Korean Language Version of the U.S. National Cancer Institute's Patient-Reported Outcomes Common Terminology Criteria for Adverse Events.

J Pain Symptom Manage. 2020-5

[10]
Validation of the caregiver Pediatric Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events measure.

Cancer. 2021-5-1

引用本文的文献

[1]
Study of Complementary and Integrative Interventions in Pediatric Patients With Serious Illness.

J Pain Symptom Manage. 2025-5

[2]
Symptom Documentation in Unstructured Palliative Care Notes of Children and Adolescents With Cancer.

J Pain Symptom Manage. 2025-4

[3]
Designing a Measure of Body Image: Cognitive Interview Findings from an Adolescent and Young Adult Cancer Sample.

J Adolesc Young Adult Oncol. 2025-4

[4]
Development and evaluation of a questionnaire to capture environmental and occupational inhalational exposures in adults with fibrotic interstitial lung disease.

Respir Res. 2024-10-15

[5]
Designing Patient-Reported Measures of Fertility: Cognitive Interview Findings from Adolescents and Young Adults with Cancer.

J Adolesc Young Adult Oncol. 2025-4

[6]
Parents' perception of treatment-related toxicity in children treated according to the NOPHO ALL2008 protocol for acute lymphoblastic leukemia.

Hemasphere. 2024-7-12

[7]
Asking the "Right" Questions about Financial Hardship: Using Cognitive Interviews with Adolescents and Young Adults with Cancer and Their Caregivers to Inform Measure Development.

J Adolesc Young Adult Oncol. 2024-10

[8]
Multilevel Characteristics of Cumulative Symptom Burden in Young Survivors of Childhood Cancer.

JAMA Netw Open. 2024-5-1

[9]
Translation and Cultural Adaptation into Arabic of Patient-Reported Outcome Measurement Information System Item Banks: Cognitive Function Abilities and Physical Function for Samples with Mobility Aid Users.

Healthcare (Basel). 2024-1-15

[10]
Agreement and disagreement between child-caregiver symptom and function reports in pediatric oncology.

Pediatr Blood Cancer. 2024-1

本文引用的文献

[1]
Concept-elicitation phase for the development of the pediatric patient-reported outcome version of the Common Terminology Criteria for Adverse Events.

Cancer. 2016-1-1

[2]
Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

JAMA Oncol. 2015-11

[3]
PROMIS(®) pediatric self-report scales distinguish subgroups of children within and across six common pediatric chronic health conditions.

Qual Life Res. 2015-9

[4]
Item-level informant discrepancies between children and their parents on the PROMIS(®) pediatric scales.

Qual Life Res. 2015-8

[5]
Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).

J Natl Cancer Inst. 2014-9-29

[6]
Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

Qual Life Res. 2013-7-20

[7]
New policies to address the global burden of childhood cancers.

Lancet Oncol. 2013-2-20

[8]
The first step to integrating the child's voice in adverse event reporting in oncology trials: a content validation study among pediatric oncology clinicians.

Pediatr Blood Cancer. 2013-1-17

[9]
Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2--assessing respondent understanding.

Value Health. 2011-10-10

[10]
Developmental differences in medial temporal lobe function during memory encoding.

J Neurosci. 2010-7-14

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索